Macrogenics reported $13.67M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.21B 4M
Amgen AMGN:US USD 1.47B 181M
AstraZeneca AZN:LN USD 3.53B 174M
Biogen BIIB:US USD 632.8M 69.5M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Daiichi Sankyo 4568:JP JPY 120.96B 7.47B
Eli Lilly And LLY:US USD 1.64B 29M
Genmab GEN:DC DKK 921M 251M
Geron GERN:US USD 13.84M 1.8M
Gilead Sciences GILD:US USD 2.02B 807M
Immunogen IMGN:US USD 42.06M 8.44M
Johnson & Johnson JNJ:US USD 6.51B 423M
Karyopharm Therapeutics KPTI:US USD 34.65M 4K
Macrogenics MGNX:US USD 13.67M 1.68M
Merk MRK:US USD 2.63B 134M
Mirati Therapeutics MRTX:US USD 70.82M 10.02M
Pfizer PFE:US USD 4.87B 1.33B
Puma Biotechnology PBYI:US USD 25.04M 1.08M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Roche Holding ROG:VX 6.48B 834M
Seattle Genetics SGEN:US USD 216.1M 5.72M
Xencor XNCR:US USD 12.75M 377K